Connect with us
Anglostratits

Business

Africa Health Excon: Positioning Africa as the continental hub for health innovation and trade

Published

on

Merck

Merck is actively bringing technical and process expertise with various key African countries and customers to build local manufacturing capabilities

CAIRO, Egypt, June 6, 2022/APO Group/ — 

The Merck (MerckGroup.com) Africa Bureau aims to accelerate the business transformation of the company operations in Africa to ensure sustainable business and create long-term value. Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals, and treatment access. Merck announced the brand-new Thyroid awareness program: ThyroAfrica to spread disease awareness. Africa Cancer Care program will be launched to enhance colorectal cancer diagnosis across Africa. Merck continues its work in the fight against Malaria and the neglected tropical disease (NTD) schistosomiasis. Merck is actively bringing technical and process expertise with various key African countries and customers to build local manufacturing capabilities.

Merck, a leading science and technology company, announced today its further commitment to Africa, by strategically expanding its access and awareness programs and strengthening the health systems and patients in low- and middle-income countries across the continent. The announcement came today during the Africa Health ExCon from 5th to 7th of June 2022 in Cairo, Egypt.

In this three-day event, stakeholders across Africa are meeting to learn from the worldwide leaders and experts in healthcare, as well as to share and exchange knowledge and experiences with more than 20,000 participants from more than 55 countries. The key objectives of Africa Health ExCon are refocusing on Africa’s investment potential, ensuring equitable access of health technology, the thriving of the health and pharma businesses, and incubating health innovation and trade in Africa.

”Our aspiration is to be one of the leading healthcare partners in sub-Saharan Africa and to work with NGOs and governments to build and strengthen sustainable health systems within it,” said Dr. Karim Bendhaou, Head of Merck Africa Bureau. “The Merck Africa Bureau aims to accelerate the business transformation of our operations in Africa to ensure sustainable business and create long-term value while seeking to balance environmental, social, and governance aspects. Through the four pillars of Private Public Partnership model, we work hand in hand with our stakeholders through various programs to fight counterfeit medicines, to invest in the technology transfer, to support supply chain sustainability and localization, and to decrease fragmentation of the market.’’

During the ExCon, Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals and treatment access. The company announced their brand-new Thyroid awareness program and upcoming launch of the Africa Cancer Care program in addition to enhancing ongoing initiatives.

Thyroid disease awareness is relatively very low in Africa. The ThyroAfrica program’s objective is to establish a collaborative partnership with the endocrinology & thyroid disease societies in Africa. This aims to increase disease awareness via communication channels for mass reach of around 7 million people and to offer the proper link for TSH (thyroid-stimulating hormone) test.

Merck has unveiled plans to expand its footprint in Africa through a four-tiered program of awareness, diagnosis, training of healthcare professionals, and treatment access

Africa Cancer Care program will be launched by the end of June to enhance colorectal cancer diagnosis across Africa by creating hubs of RAS testing in African countries such as Kenya and Nigeria. The RAS (RAT Sarcoma) test is a gene mutation analysis in colorectal cancer. As a predictive biomarker for the disease, it helps to guide treatment and determine outcomes. This would help to counteract the rising demand for specialist care especially with the existing healthcare facilities that require the scaling of resources. This has led to the rise in medical tourism across the continent, as individuals seek specialised care elsewhere. This is in addition to enhancing access to medication and providing HCP capacity-building programs through high quality trainings to oncologists, pathologists, nurses to support diagnosis and treatment of metastatic colorectal cancer in Africa.

“We will remain fully committed to increase access to innovative medicines across Africa and on ground awareness campaigns in a favour of underserved populations in low- and middle-income countries in Africa through our investments and our innovations in science & technology, together with our external partners,” said Ramsey Morad, Regional Vice-President, Head Middle East, Africa, Turkey & Russia/CIS at Merck Healthcare. “Beyond developing novel treatments, we must address the gaps in awareness, accessibility, affordability and availability of treatment.’’

After having signed a Memorandum of Understanding, Merck and the African Federation for Fertility Societies (AFFS) have been jointly working on an agenda to further develop educational training programs for healthcare professionals, aimed at improving access to high-quality infertility care for patients in Africa. By combining their forces, AFFS has sought support from Merck in order to develop a regional patient awareness campaign to be launched later this year. Additionally, they are hosting a multi-national advisory board to gain insights on educational gaps for healthcare professionals in AFFS member societies in African countries.

Professor Gamal Serour, President of African Federation of Fertility Societies stated that “AFFS welcomes and appreciates collaboration with Merck for the implementation of high-quality care across Africa”.

Merck also continues its work in the fight towards the elimination of the neglected tropical disease (NTD) schistosomiasis towards its elimination as a public health burden. In partnership with the World Health Organization (WHO), we provide up to 250 million tablets of praziquantel per year to treat mainly school-aged children in sub-Saharan Africa (SSA).  Since 2007, Merck has donated over 1.5 billion tablets and enabled the treatment of more than 600 million school-aged children in 47 countries in SSA. To support the elimination of schistosomiasis, Merck have adopted an integrated approach which, beyond medicines, includes health education as well as water, sanitation and hygiene (WASH) initiatives. We also conduct research for new drugs and diagnostics and develop, together with a consortium of partners, a potential new paediatric treatment option for children as of 6 years of age and below.

Since 2015, Merck has also been very active in the fight against malaria through a holistic approach to prevent, control, and eliminate the disease. Examples include our M5717 drug development program as well as the creation of the Pan African Vivax and Ovale Network (PAVON) in over 10 countries, which has led to important policy changes regarding malaria in Botswana.

During the ExCon, Merck aims to strengthen our existing cooperation with the Pharma industry and Medicine & Quality Regulators across the continent in addition to highlighting strategic projects in Africa carried out by Merck’s Life Science business sector. These efforts bring our expertise in touch with various key African countries and research institutes to enable distributed manufacturing of much-needed vaccines, biological drugs, and therapies in African countries. “Our goal at Merck is to support capacity-building of biologics manufacturing and development in Africa,” said Youssef Gaabouri, Head of Sales Middle East & Africa at Merck Life Science BioProcessing. Furthermore, Merck provides expertise to Regulatory Agencies and shares knowledge regarding the use of quality products for audit purposes. In line with the Merck’s commitment to sustainable access to health solutions in low- and middle-income countries, we implement and enhance health access programs through our shared value initiatives, global health partnerships, and access to medicine strategy.

Distributed by APO Group on behalf of Merck.

Business

Libya Energy & Economic Summit (LEES) 2027 International Pavilions to Connect Global Companies to Libyan Projects

Published

on

Etu Energias

The UK, France, Italy and the U.S. will host international pavilions at the upcoming summit, creating commercial pathways for international companies in Libya’s energy sector

TRIPOLI, Libya, November 17, 2026/APO Group/ –The fifth Libya Energy & Economic Summit (LEES) will bring international investors to Tripoli from January 23–25, 2027, as the country targets two million barrels per day and seeks an estimated $36–$40 billion in investment to support its production expansion.

 




  

International pavilions will connect companies with Libyan stakeholders across oil and gas, infrastructure, renewables and industry. Business France, the Italian Trade Agency (ITA), the American Chamber of Commerce in Libya (AmCham Libya) and the Libyan British Business Council (LBBC) are expanding their platforms for companies seeking partnerships and commercial opportunities in Libya.

UK Pavilion

The LBBC, together with the British Embassy in Libya, will host the UK Pavilion, building on the UK’s participation at LEES 2026. The pavilion will showcase UK companies and international businesses with UK operations, while providing one-to-one meetings, roundtables and networking with Libyan stakeholders.

British participation comes as companies including bp pursue exploration and field redevelopment opportunities, while UK engineering, consultancy and financial expertise can support Libya’s infrastructure and production expansion.

France Pavilion

Business France will organize the France Pavilion, extending a strong presence that included 19 French companies at LEES 2026. The pavilion will provide a platform for French energy, engineering and infrastructure companies to pursue opportunities across hydrocarbons, solar power and wider economic development.

TotalEnergies remains the flagship French investor, with its Libyan operations spanning oil and gas production, field development and renewable energy. The company is also advancing the 500 MW Sadada solar project, which is expected to become Libya’s first utility-scale solar development and support the country’s broader energy diversification.

Italy Pavilion

Italy’s presence will build on the ITA pavilion and the Italy-Libya business engagement established at LEES 2026. Italian companies are positioned across energy, engineering, valves, fire protection and industrial services, with Eni remaining the country’s strategic anchor.

Eni continues expanding Libyan exploration and gas development, including offshore activities in the Sirte Basin and major projects designed to increase domestic gas supply.

U.S. Pavilion

U.S. participation will be strengthened through AmCham Libya, which supported a major American corporate presence at LEES 2026. Anchor participants included ConocoPhillips, Halliburton, NOV and Caterpillar, reflecting U.S. expertise across drilling, oilfield services and heavy equipment.

LEES 2027 will also host a U.S.-MENA Strategic Forum, focusing on upstream investment, technology, infrastructure and broader U.S.-Libya commercial cooperation.

As the country pursues major production, infrastructure and industrial investments, LEES 2027 will position these pavilions as commercial gateways into one of Africa’s most significant emerging energy markets.

For more information about LEES 2027, visit www.LibyaSummit.com. To sponsor or participate as a delegate, contact sales@energycapitalpower.com.

Distributed by APO Group on behalf of Energy Capital & Power.

 

 




 

Continue Reading

Business

Mauritania Gateway to Lead Business Delegation to MSGBC Oil, Gas & Power 2026

Published

on

Etu Energias

The Mauritanian investment platform will open its vetted business network to delegates seeking partners in the country

DAKAR, Senegal, November 17, 2026/APO Group/ –Mauritania Gateway has joined MSGBC Oil, Gas & Power 2026 as a Strategic Partner and will lead a delegation of Mauritanian businesses and institutions to the conference in Dakar. The independent investment platform connects international companies with Mauritanian operators and government stakeholders. The partnership comes as Mauritania’s gas sector expands beyond LNG exports into domestic power and industry, creating procurement opportunities for international firms with capable local partners.

 




  

Mauritania Gateway has spent eight years building commercial links between Mauritania and international markets, organizing more than 20 trade missions with participation from more than 2,000 companies. The platform supports entry into the Mauritanian market through sector research, tender tracking and local partner screening, and admits firms to its business community through a selective vetting process. Its clients include renewable energy developers CWP Global and GreenGo Energy, as well as Meen&Meen, a Mauritanian engineering consultancy serving the mining and hydrocarbons industries.

Domestic gas use is widening the market for local partnerships in Mauritania and across the MSGBC basin. The Greater Tortue Ahmeyim (GTA) project on the Senegal-Mauritania maritime border made Mauritania an LNG exporter in 2025, and it was producing at approximately 2.65 million tons per annum in the second quarter of 2026. The GTA partners are now advancing plans to route gas into national power generation. In July 2026, Mauritania signed an agreement with Saudi developer ACWA Power for the 230 MW N’Diago plant, the country’s first large-scale gas-fired independent power project. The government expects approximately 300 MW of additional locally generated power to reach the national grid by the end of 2026.

Mining is opening another pathway for international investment. In July 2026, Mauritania became the first MSGBC basin state to sign a critical minerals framework agreement with the United States. The agreement covers geological data-sharing, skills development and local processing. Mauritania Gateway runs a dedicated mining program alongside its energy work, and its in-country network includes Abdouly Holding, which provides construction, logistics and industrial services to regional mining projects.

The Mauritania Gateway delegation will attend alongside Mauritania’s Minister of Energy and Petroleum, Mohamed Ould Abdel Vetah, whose government is using GTA gas and new mining agreements to build out domestic power and industry. A dedicated Mauritania National Spotlight will put the country’s agenda before investors and service companies evaluating entry into the Mauritanian market.

Organized by Energy Capital & Power, MSGBC Oil, Gas & Power 2026 takes place December 1–3 at the Centre International de Conférences Abdou Diouf in Dakar, under the High Patronage of President Bassirou Diomaye Faye and in partnership with Senegal’s Ministry of Energy and Petroleum. To register, visit www.MSGBCOilGasAndPower.com.

Distributed by APO Group on behalf of Energy Capital & Power.

 

 




 

Continue Reading

Business

Verdant Capital Wins Two Africa Global Funds Awards

Published

on

Verdant Capital

Together, the two accolades recognise both sides of the firm: its corporate finance advisory practice and its investment management business focused on inclusive finance across the continent

JOHANNESBURG, South Africa, November 17, 2026/APO Group/ —Verdant Capital (www.Verdant-Cap.com), the pan-African private capital investment manager and investment bank, has been recognised twice at the 2026 Africa Global Funds (AGF) Awards, winning Best Advisory Firm – Private Equity – Pan-Africa and SME Financier of the Year.

 




 
 

The awards build on a consistent run of AGF recognition. Verdant Capital was named AGF’s Best Advisory Firm -Private Equity in each of 2022, 2023, 2024 and 2025, and retains the SME Financier title it first won in 2025. Together, the two accolades recognise both sides of the firm: its corporate finance advisory practice and its investment management business focused on inclusive finance across the continent.

Best Advisory Firm – Private Equity – Pan-Africa

Verdant IMAP advisory practice spans mergers and acquisitions, debt and equity capital raising, financial institutions and restructuring. The firm has transacted in more than 30 African countries, reflecting its extensive pan-African reach and specialist expertise. Between the second half of 2025 and early 2026, Verdant Capital executed notable transactions across M&A, equity and debt.

Highlights from the period include a USD 65 million debt capital raise and offtake arrangement for a gold mining company, a USD 23.4 million equity capital raise for a leading logistics tech company, and the acquisition of a South African chrome mining complex for a leading Indian chemical group. The firm also advised on the acquisition of a South African data centre portfolio and several business sales. The firm has continued to deepen its sector expertise, building a dedicated six-person metals and mining team covering debt, equity, royalty-streaming and offtake arrangements.

The firm was also ranked second in South Africa for M&A advisory to unlisted companies by DealMakers Africa in the first quarter of 2026.

SME Financier

The SME Financier award recognises Verdant Capital’s work through the Verdant Capital Hybrid Fund (VCHF), which provides hybrid capital to inclusive financial institutions across Africa. These institutions serve micro-entrepreneurs at the “bottom of the pyramid” and SMEs in the “missing middle”, with job creation and improved livelihoods forming the fund’s primary development objectives.

VCHF hybrid capital mandate is designed to “crowd in” senior lenders, expanding the overall financing available to local financial sectors and strengthening the African impact investment ecosystem. The fund’s portfolio includes investments in asset financiers, digital lenders and other technology-enabled non-bank financial institutions. The principle developmental objective of the fund is to create jobs by supporting micro entrepreneurs and SME. The fund recently released its first impact report which reported a total of 316 000 job created as per estimates prepared by consultant 60 Decibels.

Impact and governance are central to Verdant Capital’s investment strategy. VCHF is aligned with the 2X Challenge, with women representing 40% of its investment committee and decision-making body. The fund has also joined the 2X Challenge certification pilot programme. Its environmental and social framework, validated by anchor investor KfW, incorporates international standards including the IFC Performance Standards and ILO Core Labour Standards. A dedicated Technical Assistance Facility supports investees in measuring job creation, improving impact measurement and developing gender-smart lending approaches for women-led MSMEs.

Distributed by APO Group on behalf of Verdant Capital.

 




 

Continue Reading

Trending